India, Feb. 7 -- PNN

Mumbai (Maharashtra) [India], February 7: Vaishali Pharma Limited (NSE - VAISHALI), engaged in production and marketing of a diverse range of pharmaceutical products, announced its unaudited Financial Results for Q3 & 9M FY24.

Key Financials at a Glance:

Q3 FY24

- Total Income at Rs 28.37 Cr

- EBITDA at Rs 3.42 Cr

- EBITDA Margin at 12.05%

- Net Profit at Rs 2.11 Cr

- NPM (%) at 7.44%

- EPS at Rs 1.99

9M FY24

- Total Income at Rs 55.01 Cr

- EBITDA at Rs 9.05 Cr

- EBITDA Margin at 16.45%

- Net Profit at Rs 5.4 Cr

- NPM (%) at 9.82%

- EPS at Rs 5.10

Commenting on the performance, Atul Vasani, Chairman and Managing Director of Vaishali Pharma Limited said, "We are delighted to share our Q3 FY24 results, ...